Global Cancer Gene Therapy Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 32.4% - ResearchAndMarkets.com

DUBLIN--()--The "Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global cancer gene therapy market was valued at $289 million in 2016, and is estimated to reach $2,082 million by 2023, registering a CAGR of 32.4% from 2017 to 2023.

Gene therapy is an experimental technique that encompasses the replacement of mutated genes with healthy genes. During the treatment of cancer, the genes are replaced to fight against carcinogenic tumor cells. Gene therapy is considered to be an effective treatment for chronic diseases as they cause minimum side effects with maximum efficacy.

The rise in prevalence of cancer, benefits of cancer gene therapy over conventional cancer therapies, and the advancement in this field are the major factors that drive the market growth. In addition, increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in biotechnological funding encourage the R&D activities for cancer gene therapy and thus fuel the growth of the cancer gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to restrain the market growth.

The global cancer gene therapy market is segmented based on therapy, end user, and geography. Based on therapy, it is categorized into gene induced immunotherapy, oncolytic virotherapy, and gene transfer. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Players Profiled

  • Adaptimmune
  • GlaxoSmithKline
  • Bluebird bio, Inc.
  • Merck
  • Celgene
  • Shanghai Sunway Biotech
  • BioCancell
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics
  • OncoGenex Pharmaceuticals
  • Cell Genesys
  • Advantagene
  • GenVec
  • BioCancell
  • Celgene and Epeius Biotechnologies
  • Introgen Therapeutics
  • Ziopharm Oncology
  • Shenzhen SiBiono GeneTech
  • Genelux Corporation
  • Altor Bioscience

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Cancer Gene Therapy Market, by Therapy

5 Cancer Gene Therapy Market, by Geography

6 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/2w9sbp/global_cancer?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics, Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics, Oncology Drugs